Drug Type Small molecule drug |
Synonyms SC 50605 |
Target |
Action antagonists |
Mechanism LTB4R antagonists(Leukotriene B4 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC30H35NO6S |
InChIKeyNFHKAMAWIQHXAT-UHFFFAOYSA-N |
CAS Registry162153-46-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Psoriasis | Preclinical | United States | - |